IP Library Assignment 067125/0168
Patent Assignment
Reel/Frame 067125/0168

Change of Name

Recorded: 2024-04-16 Pages: 4
Assignor
CREALTA PHARMACEUTICALS LLC
Executed: 2016-01-15
Assignee
HORIZON PHARMA RHEUMATOLOGY LLC
150 SOUTH SAUNDERS ROAD, LAKE FOREST, ILLINOIS, 60045
Covered Property (1)
Methods and Kits for Predicting Infusion Reaction Risk and Antibody-Mediated Loss of Response by Monitoring Serum Uric Acid During Pegylated Uricase Therapy
Application: 18/630,584 →
Publication: US 2024/0255496
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 16, 2024
From: ROSARIO-JANSEN, THERESA; WRIGHT, DAVID ERICK
To: SAVIENT PHARMACEUTICALS, INC.
Reel/Frame 067118/0062 →
Assignment of Assignor's Interest Apr 16, 2024
From: SAVIENT PHARMACEUTICALS, INC.
To: CREALTA PHARMACEUTICALS LLC
Reel/Frame 067125/0144 →
Assignment of Assignor's Interest Apr 16, 2024
From: HORIZON PHARMA RHEUMATOLOGY LLC
To: HORIZON THERAPEUTICS USA, INC.
Reel/Frame 067125/0650 →